Staging lymph nodes and blood at diagnosis in mycosis fungoides identifies patients at increased risk of progression to advanced stage: A retrospective cohort study.
Pamela Blair AllenAshley A McCook-VealJeffrey M SwitchenkoDarina M PaulinoTim NiyogusabaKatelin M BairdErica S TarabadkarMary Jo LechowiczPublished in: Cancer (2022)
Staging and baseline laboratory assessments with imaging, peripheral blood flow cytometry, TCR data, and LDH in patients who have newly diagnosed MF may identify those who are at risk for progression to advanced stage.
Keyphrases
- newly diagnosed
- lymph node
- flow cytometry
- peripheral blood
- end stage renal disease
- chronic kidney disease
- ejection fraction
- pet ct
- high resolution
- prognostic factors
- genome wide
- neoadjuvant chemotherapy
- electronic health record
- regulatory t cells
- machine learning
- patient reported outcomes
- immune response
- dendritic cells
- photodynamic therapy
- artificial intelligence